Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ASCL1 ChIP-seq of patient-derived-xenograft (PDX) GBM lines and RNA-seq of mouse glioma tumors

ABSTRACT: ASCL1 ChIP-seq of patient-derived-xenograft (PDX) GBM lines and RNA-seq of mouse glioma tumors

PROVIDER: PRJNA639167 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

ASCL1 ChIP-seq of patient-derived-xenograft (PDX) GBM lines

Project description:ASCL1 ChIP-seq of patient-derived-xenograft (PDX) GBM lines

| PRJNA639169 | ENA

ASCL1 ChIP-seq of patient-derived-xenograft (PDX) GBM lines

Project description:R548 and R738 PDX-GBMs were grown orthotopically in the brains of NOD-SCID mice

2020-11-05 | GSE152399 | GEO

Identifying ASCL1 target genes in primary GBM stem cell cultures [ChIP-seq]

Project description:ASCL1 mediates neuronal differentiation of GBM stem cell (GSC) cultures. We sought to identify genomic targets of ASCL1 in primary human GSC cultures. In this dataset, we include ChIP-seq data obtained from GSC cultures harbouring a CRISPR-deletion of ASCL1. We assessed differential ASCL1 binding between control and GSC cultures induced to overexpress ASCL1 after 18 hours of doxycycline treatment.

2017-07-13 | GSE87618 | GEO

Identifying ASCL1 target genes in primary GBM stem cell cultures [RNA-seq]

Project description:ASCL1 mediates neuronal differentiation of GBM stem cell (GSC) cultures. We sought to identify targets of ASCL1 in primary human GSC cultures. In this dataset, we include RNA-seq data obtained from GSC cultures harbouring a CRISPR-deletion of ASCL1. We assessed differential gene expression between control and GSC cultures induced to overexpress ASCL1 after 7 days of doxycycline treatment.

2017-07-13 | GSE87617 | GEO

Identifying ASCL1-mediated chromatin changes in primary GBM stem cell cultures [ATAC-seq]

Project description:ASCL1 mediates neuronal differentiation of GBM stem cell (GSC) cultures. We sought to identify chromatin changes upon induced ASCL1 expression in primary human GSC cultures. In this dataset, we include ATAC-seq data obtained from GSC cultures harbouring a CRISPR-deletion of ASCL1. We assessed differential ASCL1 binding between control and GSC cultures induced to overexpress ASCL1 after 14 days of doxycycline treatment.

2017-07-13 | GSE90547 | GEO

ASCL1 defines differentiation-competent GBM cells and directs neoplastic cells towards neuronal fate

Project description:We identified a subgroup of patient-derived glioblastoma (GBM) cells that express high levels of the neurogenic transcription factor, ASCL1, which predicts response to pharmacological inhibition of the Notch signaling pathway. Treatment of ASCL1hi GBM cells with a Notch signaling inhibitor induced a change in cell fate from neoplastic to neuronal. Importantly, acquisition of the neuronal fate was accompanied by a reduction in tumorigenic potential. Loss of ASCL1 in GBM cells rendered cells no longer responsive to Notch signaling inhibition and we determined ASCL1 is required for the competency of GBM cells to undergo neuronal differentiation. Enforced ASCL1 expression directed GBM cells towards a neuronal cell fate reminiscent of terminal differentiation. RNA-seq analysis of GBM cells treated with the Notch signaling inhibitor reveals neuronal target gene activation is associated with increased stoichiometric levels of ASCL1, suggesting threshold levels of ASCL1 in GBM cells governs neuronal differentiation. We demonstrate that neoplastic cells which retain expression of key neurogenic programs can have their fates redirected towards terminal differentiation. Directed fate specification to neuronal cell types by exploiting latent neurogenic programs may be a strategy to treat a subset of GBM patients. Our findings therefore highlight the potential of differentiation therapy for a subset of molecularly defined GBMs.

2017-07-21 | GSE96088 | GEO

ASCL1 mediates neuronal differentiation of primary GBM stem cell cultures upon Notch signalling blockade [RNA-seq]

Project description:ASCL1 mediates neuronal differentiation of GBM stem cell (GSC) cultures upon Notch signalling inhibition. We sought to identify gene expression changes that were specific to ASCL1 function. In this dataset, we include RNA-seq data obtained from GSC cultures harbouring wildtype or CRISPR-deletion of ASCL1. We assessed differential gene expression between wildtype and ASCL1-knockout after treatment with gamma-secretase inhibitor for 7 days.

2017-07-13 | GSE87615 | GEO

Mayo GBM Patient Derived Xenograft National Resource

Project description:Genome wide DNA methylation profiling of GBM xenografts. The Illumina EPIC 850k Human DNA methylation array used to obtain DNA methylation profiles across approximately 800,000 CpGs in GBM xenograft samples. Samples included xx GBM xenografts.

2019-06-26 | GSE132650 | GEO

Construction of GBM patient-derived xenograft mouse models

Project description:Our adult GBM patient-derived xenograft mouse models keep the genomics characteristics of GBM patient tumors.

2023-07-12 | GSE207886 | GEO

ASCL1 ChIP-seq of patient-derived-xenograft (PDX) GBM lines and RNA-seq of mouse glioma tumors

Project description:This SuperSeries is composed of the SubSeries listed below.

2020-11-05 | GSE152401 | GEO